Human neonatal rotavirus vaccine (RV3-BB) targets rotavirus from birth

BACKGROUND: A birth dose strategy using a neonatal rotavirus vaccine to target early prevention of rotavirus disease may address remaining barriers to global vaccine implementation. METHODS: We conducted a randomized, placebo-controlled trial in Indonesia to evaluate the efficacy of an oral human ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Bines, Julie E., Thobari, Jarir At, Satria, Cahya Dewi, Handley, Amanda, Watts, Emma, Cowley, Daniel, Nirwati, Hera, Ackland, James, Standish, Jane, Justice, Frances, Byars, Gabrielle, Lee, Katherine J., Barnes, Graeme L., Bachtiar, Novilia S., Icanervilia, Ajeng Viska, Boniface, Karen, Bogdanovic-Sakran, Nada, Pavlic, Daniel, Bishop, Ruth F., Kirkwood, Carl D., Buttery, Jim P., Soenarto, Yati
Format: Artigo
Idioma:Inglês
Publicat: Massachusetts Medical Society 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774175/
https://ncbi.nlm.nih.gov/pubmed/29466164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1706804
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars